Nalaganje...
MINIMAL RESIDUAL DISEASE IN ACUTE LYMPHOBLASTIC LEUKEMIA
In patients with acute lymphoblastic leukemia (ALL), monitoring of minimal residual disease (MRD) offers a way to precisely assess early treatment response and detect relapse. Established methods to study MRD are flow cytometric detection of abnormal immunophenotypes, polymerase chain reaction (PCR)...
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2009
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2632881/ https://ncbi.nlm.nih.gov/pubmed/19100372 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminhematol.2008.09.001 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|